Related Experiment Video
Updated: Nov 23, 2025
14:45
Technical Detail for Robot Assisted Pancreaticoduodenectomy
Published on: September 28, 2019
15.1K
Role of Node Dissection in Pancreatic Tumor Resection
Mary Dillhoff1,2, Timothy M Pawlik3
1Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. mary.dillhoff@osumc.edu.
Annals of Surgical Oncology
|January 4, 2021
Summary
Extended lymphadenectomy does not improve survival in pancreatic cancer patients. This surgical approach increases complications and hospital stay, offering no survival benefit for this lethal disease.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Pancreatic cancer has a high mortality rate, with limited improvement from current therapies.
- Lymph node status is critical for prognosis, but the benefit of extensive lymph node removal is debated.
- Six randomized controlled trials (RCTs) have investigated lymph node dissection extent during pancreaticoduodenectomy.
Purpose of the Study:
- To review existing literature on the role of lymphadenectomy in pancreatic cancer.
- To evaluate the impact and contribution of individual RCTs to the understanding of lymphadenectomy in pancreatic cancer.
Main Methods:
- Systematic review of six randomized controlled trials.
- Analysis of data concerning lymphadenectomy extent in pancreaticoduodenectomy.
Main Results:
- Multiple RCTs found no significant improvement in overall survival with extended lymphadenectomy.
- Extended lymphadenectomy was linked to increased patient morbidity.
- Extended lymphadenectomy also led to longer operating room times and hospital stays.
Conclusions:
- Extended lymphadenectomy offers no survival advantage for pancreatic cancer.
- The procedure is associated with increased complications and resource utilization.
- Current evidence does not support routine extended lymphadenectomy for pancreatic cancer.
